Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC Chair Lina Khan said in a "60 Minutes" interview that hundreds of acquisitions by Big Tech players like Facebook led to ...
Grocery chains Kroger and Albertsons want to merge. It's a move Federal Trade Commission Chair Lina Khan worries could hurt ...
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback